Sevan Hakgor

An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)

Derek Clouthier, Scott Lien, S.Y. Cindy Yang et al. · Journal for ImmunoTherapy of Cancer · 2019 · 55 citations · Full text

Life Sciences, Immunology, Oncology +17

Implications of Selection Bias Due to Delayed Study Entry in Clinical Genomic Studies

Samantha Brown, Jessica A. Lavery, Ronglai Shen et al. · JAMA Oncology · 2021 · 50 citations · Full text

Medicine, Biostatistics, Oncology +15

Correlation Between Surrogate End Points and Overall Survival in a Multi-institutional Clinicogenomic Cohort of Patients With Non–Small Cell Lung or Colorectal Cancer

Kenneth L. Kehl, Gregory J. Riely, Eva M. Lepisto et al. · JAMA Network Open · 2021 · 40 citations · Full text

Medicine, Biostatistics, Oncology +17

CanDIG: Federated network across Canada for multi-omic and health data discovery and analysis

Lewis Jonathan Dursi, Zoltán Bozóky, Richard de Borja et al. · Cell Genomics · 2021 · 27 citations · Full text

Medicine, Bioinformatics, Biomedical Informatics +17

Predicting Toxicity and Response to Pembrolizumab Through Germline Genomic HLA Class 1 Analysis

Marco Iafolla, Cindy Yang, Vinod Chandran et al. · JNCI Cancer Spectrum · 2020 · 23 citations · Full text

Life Sciences, Immunology, Oncology +17